Elimination of measles--South Korea, 2001-2006

    Insights

    South Korea achieved measles elimination by implementing a 5-year National Measles Elimination Plan. This plan successfully interrupted indigenous measles transmission, marking a significant public health achievement.

    Area of Science:

    • Public Health
    • Epidemiology
    • Immunization Programs

    Background:

    • Measles was endemic in South Korea prior to the introduction of measles-containing vaccine (MCV).
    • National immunization programs evolved, introducing a single dose of MCV in 1965 and the measles, mumps, and rubella (MMR) vaccine in 1983.
    • A second MCV dose (MCV2) was added in 1997, but low coverage (39% in a 2000 study) persisted due to insufficient policy support.

    Purpose of the Study:

    • To describe the activities undertaken as part of South Korea's National Measles Elimination Plan.
    • To summarize the results of the 5-year plan initiated in response to a 2000-2001 measles epidemic.
    • To document the achievement of interrupting indigenous measles transmission in South Korea.

    Main Methods:

    • Implementation of a comprehensive 5-year National Measles Elimination Plan starting in 2001.
    • Strengthening policies and programs to improve two-dose MCV coverage.
    • Monitoring and surveillance to track measles transmission and vaccination rates.

    Main Results:

    • Successful interruption of indigenous measles transmission achieved by late 2006.
    • South Korea became the first country in the WHO Western Pacific Region to declare measles elimination.
    • The National Measles Elimination Plan effectively addressed a significant measles epidemic.

    Conclusions:

    • The strategic implementation of the National Measles Elimination Plan was pivotal in achieving measles elimination.
    • Sustained political will and program support are crucial for successful vaccine-preventable disease eradication.
    • South Korea's experience provides a model for other nations aiming for measles elimination.

    Related Concept Videos

    Respiratory Syncytial Virus Disease01:29

    Respiratory Syncytial Virus Disease

    Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
    Vaccinations01:51

    Vaccinations

    Overview
    Smallpox01:24

    Smallpox

    Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
    Poliomyelitis01:17

    Poliomyelitis

    Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
    Enhanced Elimination of Poison01:26

    Enhanced Elimination of Poison

    Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
    Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
    Renal excretion is the...
    Transmission-based Precautions II: Airborne and Protective Environment01:25

    Transmission-based Precautions II: Airborne and Protective Environment

    Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
    Airborne precautions:
    Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...